Hyong Kim Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 weeks, 1 day ago
Hyong Kim has an estimated net worth of at least $10.6 million*, as of Sept. 9, 2026. They own 299,271 shares of ALHC stock. They have sold 431,272 shares of ALHC stock since 2021, for an estimated $6.4 million.
Hyong Kim $ALHC SEC Form 4 Insider Trading
Hyong Kim has filed a total of 21 insider trades in $ALHC since 2021. Their most recent trade was a sale of 32,479 shares, made on Oct 06, 2026. Their largest trade was a sale of 62,574 shares, made on Dec 05, 2024. We estimate that they now own 299,271 shares of $ALHC, worth an estimated $4.2 million.
Insider Trading at $ALHC
There have been a total of 382 insider trades reported at $ALHC since 2021, with 217,848 shares purchased and 155.1 million shares sold. The most active insider traders in $ALHC stock have been John E Kao, Robert Thomas Freeman, and Dawn Christine Maroney. The most recent trade was a sale of 32,479 shares reported by Hyong Kim (Chief Medical Officer), made on Oct 06, 2026.
History of Insider Stock Trades by Hyong Kim
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 32,479 | Oct 06, 2026 | Oct. 7, 2026, 4 p.m. |
|
ALHC
|
Sale | 35,951 | Jun 12, 2026 | June 15, 2026, 9:57 p.m. |
|
ALHC
|
Sale | 18,404 | Mar 18, 2026 | March 19, 2026, 6:42 p.m. |
|
ALHC
|
Sale | 16,506 | Jan 06, 2026 | Jan. 6, 2026, 7:19 p.m. |
|
ALHC
|
Sale | 11,998 | Dec 29, 2025 | Dec. 30, 2025, 5:57 p.m. |
|
ALHC
|
Sale | 696 | Dec 29, 2025 | Dec. 30, 2025, 5:57 p.m. |
|
ALHC
|
Sale | 51,379 | Oct 09, 2025 | Oct. 10, 2025, 7:59 a.m. |
|
ALHC
|
Sale | 33,655 | Oct 08, 2025 | Oct. 10, 2025, 7:59 a.m. |
|
ALHC
|
Sale | 24,800 | Aug 22, 2025 | Aug. 22, 2025, 5:44 p.m. |
|
ALHC
|
Sale | 18,600 | Aug 13, 2025 | Aug. 15, 2025, 4:31 p.m. |
|
ALHC
|
Sale | 18,600 | Aug 11, 2025 | Aug. 13, 2025, 4:24 p.m. |
|
ALHC
|
Sale | 26,734 | Mar 20, 2025 | March 21, 2025, 7:12 p.m. |
|
ALHC
|
Sale | 2,971 | Mar 19, 2025 | March 19, 2025, 9:50 p.m. |
|
ALHC
|
Sale | 5,295 | Mar 19, 2025 | March 19, 2025, 9:50 p.m. |
|
ALHC
|
Sale | 21,006 | Mar 07, 2025 | March 7, 2025, 7:37 p.m. |
|
ALHC
|
Sale | 568 | Mar 07, 2025 | March 7, 2025, 7:37 p.m. |
|
ALHC
|
Sale | 13,394 | Mar 05, 2025 | March 6, 2025, 8:31 p.m. |
|
ALHC
|
Sale | 7,626 | Mar 06, 2025 | March 6, 2025, 8:31 p.m. |
|
ALHC
|
Sale | 62,574 | Dec 05, 2024 | Dec. 6, 2024, 5:30 p.m. |
|
ALHC
|
Sale | 22,460 | Oct 08, 2024 | Oct. 10, 2024, 6:58 p.m. |
|
ALHC
|
Sale | 5,576 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
John E Kao, Chief Executive Officer
-
Robert Thomas Freeman, Chief Financial Officer
-
Dawn Christine Maroney, President
-
Dawn Christine Maroney, President, Markets
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Hakan Kardes, Chief Experience Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Joseph S Konowiecki, Chairman of the Board
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, EVP, Corporate Affairs
-
Richard A. Cross, SVP, General Counsel
-
Donald Steven Furman, Chief Clinical Officer
-
James M Head, Chief Financial Officer
-
Mark D. Kent, President - MSO
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.